首页
订购/客服:400-666-5481

RIP2 kinase inhibitor 1

    
≥98%

RIP2 kinase inhibitor 1

源叶(MedMol)
S83247 一键复制产品信息
1423186-80-4
C21H22N4O4S2
458.5538
GSK2983559 active metabolite
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S83247-1mg
≥98%

¥420.00

货期:3-5天 - - - -
S83247-5mg
≥98%

¥990.00

货期:3-5天 - - - -
S83247-10mg
≥98%

¥1560.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
靶点: RIP2 Kinase;RIPkinase
体外研究: GSK2983559 active metabolite is a novel prodrug of a quinazolyl amine that inhibits RIP2 kinase. Receptor interacting protein-2 (RIP2) kinase, which is also referred to as CARD3, RICK, CARDIAK, or RIPK2, is a TKL family serine/threonine protein kinase involved in innate immune signaling. RIP2 kinase is composed of an N-terminal kinase domain and a C-terminal caspase-recruitment domain (CARD) linked via an intermediate (IM) region. The CARD domain of RIP2 kinase mediates interaction with other CARD-containing proteins, such as NODI and NOD2. NODI and NOD2 are cytoplasmic receptors which play a key role in innate immune surveillance. They recognize both gram positive and gram negative bacterial pathogens and are activated by specific peptidoglycan motifs, diaminopimelic acid (i.e., DAP) and muramyl dipeptide
参考文献: 1. Linda N. Casillas, et al. Prodrugs of amino quinazoline kinase inhibitor. PCT Int. Appl. (2014), WO 2014043446 A1 20140320.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.181 ml 10.904 ml 21.808 ml
5 mM 0.436 ml 2.181 ml 4.362 ml
10 mM 0.218 ml 1.09 ml 2.181 ml
50 mM 0.044 ml 0.218 ml 0.436 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×